Molecular diagnostic techniques are particularly impactful in the field of oncology. By identifying specific biomarkers and genetic mutations associated with different types of cancer, these methods help in tailoring treatment strategies. For instance, the detection of mutations in the KRAS or EGFR genes can guide the use of targeted therapies in lung and colorectal cancers. Moreover, molecular profiling aids in predicting disease outcomes and monitoring treatment responses.
